140 related articles for article (PubMed ID: 25421342)
1. EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control.
Pokhrel S; Evers S; Leidl R; Trapero-Bertran M; Kalo Z; Vries Hd; Crossfield A; Andrews F; Rutter A; Coyle K; Lester-George A; West R; Owen L; Jones T; Vogl M; Radu-Loghin C; Voko Z; Huic M; Coyle D
BMJ Open; 2014 Nov; 4(11):e006945. PubMed ID: 25421342
[TBL] [Abstract][Full Text] [Related]
2. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
[TBL] [Abstract][Full Text] [Related]
3. Estimates of costs for modelling return on investment from smoking cessation interventions.
Trapero-Bertran M; Leidl R; Muñoz C; Kulchaitanaroaj P; Coyle K; Präger M; Józwiak-Hagymásy J; Cheung KL; Hiligsmann M; Pokhrel S;
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):32-41. PubMed ID: 29532538
[TBL] [Abstract][Full Text] [Related]
4. [A return on investment tool in tobacco control: what do stakeholders think?].
Muñoz C; Trapero-Bertran M; Cheung KL; Evers S; Hiligsmann M; de Vries H; López-Nicolás Á
Gac Sanit; 2016; 30(2):121-5. PubMed ID: 26656947
[TBL] [Abstract][Full Text] [Related]
5. Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation.
Coyle K; Coyle D; Lester-George A; West R; Nemeth B; Hiligsmann M; Trapero-Bertran M; Leidl R; Pokhrel S;
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):7-18. PubMed ID: 28833765
[TBL] [Abstract][Full Text] [Related]
6. A utility of model input uncertainty analysis in transferring tobacco control-related economic evidence to countries with scarce resources: results from the EQUIPT study.
Németh B; Kulchaitanaroaj P; Lester-George A; Huic M; Coyle K; Coyle D; Pokhrel S; Kaló Z
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):42-51. PubMed ID: 29377316
[TBL] [Abstract][Full Text] [Related]
7. Understanding perceived availability and importance of tobacco control interventions to inform European adoption of a UK economic model: a cross-sectional study.
Kulchaitanaroaj P; Kaló Z; West R; Cheung KL; Evers S; Vokó Z; Hiligsmann M; de Vries H; Owen L; Trapero-Bertran M; Leidl R; Pokhrel S
BMC Health Serv Res; 2018 Feb; 18(1):115. PubMed ID: 29444679
[TBL] [Abstract][Full Text] [Related]
8. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
9. Understanding the stakeholders' intention to use economic decision-support tools: A cross-sectional study with the tobacco return on investment tool.
Cheung KL; Evers SM; Hiligsmann M; Vokó Z; Pokhrel S; Jones T; Muñoz C; Wolfenstetter SB; Józwiak-Hagymásy J; de Vries H
Health Policy; 2016 Jan; 120(1):46-54. PubMed ID: 26718686
[TBL] [Abstract][Full Text] [Related]
10. The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study.
Pichon-Riviere A; Alcaraz A; Palacios A; Rodríguez B; Reynales-Shigematsu LM; Pinto M; Castillo-Riquelme M; Peña Torres E; Osorio DI; Huayanay L; Loza Munarriz C; de Miera-Juárez BS; Gallegos-Rivero V; De La Puente C; Del Pilar Navia-Bueno M; Caporale J; Roberti J; Virgilio SA; Augustovski F; Bardach A
Lancet Glob Health; 2020 Oct; 8(10):e1282-e1294. PubMed ID: 32971051
[TBL] [Abstract][Full Text] [Related]
11. Comparing the effectiveness and cost-effectiveness of self-management interventions in four high-priority chronic conditions in Europe (COMPAR-EU): a research protocol.
Ballester M; Orrego C; Heijmans M; Alonso-Coello P; Versteegh MM; Mavridis D; Groene O; Immonen K; Wagner C; Canelo-Aybar C; Sunol R;
BMJ Open; 2020 Jan; 10(1):e034680. PubMed ID: 31959612
[TBL] [Abstract][Full Text] [Related]
12. Quitting behaviours and cessation methods used in eight European Countries in 2018: findings from the EUREST-PLUS ITC Europe Surveys.
Papadakis S; Katsaounou P; Kyriakos CN; Balmford J; Tzavara C; Girvalaki C; Driezen P; Filippidis FT; Herbeć A; Hummel K; McNeill A; Mons U; Fernández E; Fu M; Trofor AC; Demjén T; Zatoński WA; Willemsen M; Fong GT; Vardavas CI;
Eur J Public Health; 2020 Jul; 30(Suppl_3):iii26-iii33. PubMed ID: 32918825
[TBL] [Abstract][Full Text] [Related]
13. Estimating the public economic consequences of introducing varenicline smoking cessation therapy in South Korea using a fiscal analytic framework.
Connolly MP; Baker CL; Kotsopoulos N
J Med Econ; 2018 Jun; 21(6):571-576. PubMed ID: 29376747
[TBL] [Abstract][Full Text] [Related]
14. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America.
Pichon-Riviere A; Augustovski F; Bardach A; Colantonio L;
Value Health; 2011; 14(5 Suppl 1):S51-9. PubMed ID: 21839900
[TBL] [Abstract][Full Text] [Related]
16. Economic Evaluation of Five Tobacco Control Policies Across Seven European Countries.
Leão T; Perelman J; Clancy L; Mlinarić M; Kinnunen JM; Nuyts PAW; Mélard N; Rimpelä A; Lorant V; Kunst AE
Nicotine Tob Res; 2020 Jun; 22(7):1202-1209. PubMed ID: 31350556
[TBL] [Abstract][Full Text] [Related]
17. Evidence From Qualitative Studies of Youth About the Impacts of Tobacco Control Policy on Young People in Europe: A Systematic Review.
Papanastasiou N; Hill S; Amos A
Nicotine Tob Res; 2019 Jun; 21(7):863-870. PubMed ID: 29370431
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of exercise referral schemes enhanced by self-management strategies to battle sedentary behaviour in older adults: protocol for an economic evaluation alongside the SITLESS three-armed pragmatic randomised controlled trial.
Deidda M; Coll-Planas L; Giné-Garriga M; Guerra-Balic M; Roqué I Figuls M; Tully MA; Caserotti P; Rothenbacher D; Salvà Casanovas A; Kee F; Blackburn NE; Wilson JJ; Skjødt M; Denkinger M; Wirth K; McIntosh E;
BMJ Open; 2018 Oct; 8(10):e022266. PubMed ID: 30327403
[TBL] [Abstract][Full Text] [Related]
19. A review of economic evaluations of tobacco control programs.
Kahende JW; Loomis BR; Adhikari B; Marshall L
Int J Environ Res Public Health; 2009 Jan; 6(1):51-68. PubMed ID: 19440269
[TBL] [Abstract][Full Text] [Related]
20. Health technology assessment of medical devices: What is different? An overview of three European projects.
Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
